Cantargia Future Growth
Future criteria checks 2/6
Cantargia's earnings are forecast to decline at 3.4% per annum while its annual revenue is expected to grow at 50.1% per year. EPS is expected to decline by 21.2% per annum.
Key information
-3.4%
Earnings growth rate
-21.2%
EPS growth rate
| Biotechs earnings growth | 42.4% |
| Revenue growth rate | 50.1% |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | 18 Nov 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 18 | -229 | -163 | -148 | 3 |
| 12/31/2025 | 194 | -36 | -147 | 69 | 3 |
| 12/31/2024 | N/A | -166 | -207 | -187 | 3 |
| 9/30/2024 | N/A | -194 | -193 | -193 | N/A |
| 6/30/2024 | N/A | -228 | -234 | -234 | N/A |
| 3/31/2024 | N/A | -241 | -267 | -267 | N/A |
| 12/31/2023 | N/A | -280 | -287 | -287 | N/A |
| 9/30/2023 | N/A | -299 | -299 | -292 | N/A |
| 6/30/2023 | N/A | -293 | -295 | -287 | N/A |
| 3/31/2023 | N/A | -330 | -320 | -313 | N/A |
| 12/31/2022 | N/A | -372 | -366 | -359 | N/A |
| 9/30/2022 | N/A | -385 | -387 | -387 | N/A |
| 6/30/2022 | N/A | -419 | -419 | -419 | N/A |
| 3/31/2022 | N/A | -411 | -406 | -406 | N/A |
| 12/31/2021 | N/A | -367 | -347 | -346 | N/A |
| 9/30/2021 | N/A | -319 | -302 | -301 | N/A |
| 6/30/2021 | N/A | -255 | -231 | -230 | N/A |
| 3/31/2021 | N/A | -206 | -187 | -186 | N/A |
| 12/31/2020 | N/A | -173 | -165 | -156 | N/A |
| 9/30/2020 | N/A | -153 | -165 | -149 | N/A |
| 6/30/2020 | N/A | -139 | -151 | -135 | N/A |
| 3/31/2020 | N/A | -127 | -144 | -129 | N/A |
| 12/31/2019 | N/A | -111 | -118 | -111 | N/A |
| 9/30/2019 | N/A | -102 | -97 | -97 | N/A |
| 6/30/2019 | N/A | -98 | -92 | -92 | N/A |
| 3/31/2019 | N/A | -101 | -88 | -88 | N/A |
| 12/31/2018 | N/A | -91 | -105 | -105 | N/A |
| 9/30/2018 | N/A | -78 | -72 | -72 | N/A |
| 6/30/2018 | N/A | -68 | N/A | -65 | N/A |
| 3/31/2018 | N/A | -56 | N/A | -54 | N/A |
| 12/31/2017 | N/A | -60 | N/A | -41 | N/A |
| 9/30/2017 | N/A | -65 | N/A | -69 | N/A |
| 6/30/2017 | N/A | -66 | N/A | -64 | N/A |
| 3/31/2017 | N/A | -58 | N/A | -54 | N/A |
| 12/31/2016 | N/A | -47 | N/A | -42 | N/A |
| 9/30/2016 | N/A | -34 | N/A | -26 | N/A |
| 6/30/2016 | N/A | -24 | N/A | -21 | N/A |
| 3/31/2016 | N/A | -22 | N/A | -19 | N/A |
| 12/31/2015 | N/A | -17 | N/A | -30 | N/A |
| 9/30/2015 | N/A | -15 | N/A | -35 | N/A |
| 6/30/2015 | N/A | -14 | N/A | -13 | N/A |
| 3/31/2015 | N/A | -10 | N/A | -10 | N/A |
| 12/31/2014 | N/A | -8 | N/A | 7 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 7V3 is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: 7V3 is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: 7V3 is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: 7V3's revenue (50.1% per year) is forecast to grow faster than the German market (5.6% per year).
High Growth Revenue: 7V3's revenue (50.1% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if 7V3's Return on Equity is forecast to be high in 3 years time